摘要
肺肝样腺癌为罕见的非小细胞肺癌类型,恶性程度高,生存期短,多以个案形式报道。本文报道了首例合并间质-上皮细胞转化因子扩增的肺肝样腺癌病例,并结合相关文献,讨论该病发病特点、病理、诊治及预后。
Hepatoid adenocarcinoma of the lung is a rare type of non-small cell lung cancer(NSCLC)with high degree of malignancy and short survival,and is usually reported in individual cases.Here,we first reported a case of pulmonary hepatoid adenocarcinoma with mesenchymal-epithelial transition factor amplification.At the same time,we discussed the characteristics,pathology,diagnosis,treatment and prognosis of the disease by combined with relevant literatures.
作者
李青
刘志峰
张恩宁
付爱芹
Li Qing;Liu Zhifeng;Zhang Enning;Fu Aiqin(Department of Oncology,Yantaishan Hospital Affiliated to Binzhou Medical University,Yantai 264025,China;Department of Pathology,Yantaishan Hospital Affiliated to Binzhou Medical University,Yantai 264003,China)
出处
《中华转移性肿瘤杂志》
2023年第2期151-154,共4页
Chinese Journal of Metastatic Cancer
基金
烟台市科技计划项目(2021YD035)
山东省医药卫生科技发展计划项目(202003100409)
关键词
肺肿瘤
肝样腺癌
间质-上皮细胞转化因子扩增
Lung neoplasms
Hepatoid adenocarcinoma
Mesenchymal-epithelial transition factor amplification